For the year ending 2025-12-31, FATE made $6,646K in revenue. -$136,467K in net income. Net profit margin of -2053.37%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Collaboration revenue | 6,646 | |||
| Research and development | 107,829 | |||
| General and administrative | 46,521 | |||
| Impairment loss | 0 | |||
| Total operating expenses | 154,350 | |||
| Loss from operations | -147,704 | |||
| Interest income | 11,052 | |||
| Change in fair value of stock price appreciation milestones | -244 | |||
| Other income | 93 | |||
| Total other income | 11,389 | |||
| Net loss | -136,315 | |||
| Unrealized gain (loss) on available-for-sale securities, net | -152 | |||
| Comprehensive loss | -136,467 | |||
| Basic EPS | -1.15 | |||
| Diluted EPS | -1.15 | |||
| Basic Average Shares | 118,789,974 | |||
| Diluted Average Shares | 118,789,974 | |||
FATE THERAPEUTICS INC (FATE)
FATE THERAPEUTICS INC (FATE)